Proactive Investors - Run By Investors For Investors

Price Bailey opportunity 'too good to miss' says Tavistock's Raven

Tavistock Investments' (LON:TAVI) acquisition of Price Bailey was too good an opportunity to turn down Brian Raven, chief executive, told Proactive Investors.

Talks had been underway for two years before the deal was struck he added.

Price Bailey brings with it a chunk of high net worth clients, a profitable advisory business and the chance to build a significant private client operation with an award winning business.

Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full TAVI profile View Profile

Tavistock Investments Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use